Cite
Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas.
MLA
Dwivedi, Smriti Sudhanshu, et al. “Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, P53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with Special Reference to Papillary Thyroid Carcinomas.” Journal of Clinical & Diagnostic Research, vol. 10, no. 12, Dec. 2016, pp. 14–19. EBSCOhost, https://doi.org/10.7860/JCDR/2016/22428.9114.
APA
Dwivedi, S. S., Khandeparkar, S. G. S., Joshi, A. R., Kulkarni, M. M., Bhayekar, P., Jadhav, A., Nayar, M., & Kambale, N. S. (2016). Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas. Journal of Clinical & Diagnostic Research, 10(12), 14–19. https://doi.org/10.7860/JCDR/2016/22428.9114
Chicago
Dwivedi, Smriti Sudhanshu, Siddhi Gaurish Sinai Khandeparkar, Avinash R. Joshi, Maithili Mandar Kulkarni, Pallavi Bhayekar, Amruta Jadhav, Musphera Nayar, and Neelam S. Kambale. 2016. “Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, P53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with Special Reference to Papillary Thyroid Carcinomas.” Journal of Clinical & Diagnostic Research 10 (12): 14–19. doi:10.7860/JCDR/2016/22428.9114.